Capital Fund Management (CFM)
RARE icon

Capital Fund Management (CFM)’s Ultragenyx Pharmaceutical RARE Stock Holding History

Capital Fund Management (CFM)’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.54M Sell
121,374
-28,827
-19% -$649K 0.01% 1244
2025
Q4 		$3.45M Sell
150,201
-26,860
-15% -$883K 0.01% 1397
2025
Q3 		$5.33M Buy
177,061
+85,074
+92% +$2.55M 0.01% 1210
2025
Q2 		$3.34M Buy
91,987
+43,903
+91% +$1.58M 0.01% 1396
2025
Q1 		$1.74M Buy
48,084
+13,859
+40% +$577K 0.01% 1476
2024
Q4 		$1.44M Sell
34,225
-2,286
-6% -$113K ﹤0.01% 1638
2024
Q3 		$2.03M Buy
36,511
+21,515
+143% +$1.1M 0.01% 1430
2024
Q2 		$616K Buy
+14,996
New +$640K ﹤0.01% 1717
2023
Q2 		– Sell
-14,398
Closed -$577K – 1858
2023
Q1 		$577K Buy
14,398
+1,081
+8% +$46.4K ﹤0.01% 1423
2022
Q4 		$617K Sell
13,317
-37,649
-74% -$1.48M ﹤0.01% 1235
2022
Q3 		$2.11M Buy
+50,966
New +$2.62M 0.02% 849
2017
Q3 		– Sell
-40,800
Closed -$2.53M – 1704
2017
Q2 		$2.53M Buy
+40,800
New +$2.46M 0.02% 651
2016
Q2 		– Sell
-4,277
Closed -$271K – 1731
2016
Q1 		$271K Buy
+4,277
New +$280K ﹤0.01% 1353

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital Fund Management (CFM)'s RARE Position: Q1 2026 in Review

Capital Fund Management (CFM) reduced its Ultragenyx Pharmaceutical (RARE) stake by 19% in Q1 2026, selling an estimated $649K and leaving 121,374 shares worth $2.54M. The position accounts for 0.01% of the portfolio, ranked #1244.

Capital Fund Management (CFM) first reported a position in RARE in Q1 2016 and has held it in 13 quarters since. The position peaked at $5.33M in Q3 2025. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Capital Fund Management (CFM) held 121,374 shares of Ultragenyx Pharmaceutical worth $2.54M as of Q1 2026.
  • Capital Fund Management (CFM) sold 28,827 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $649K.
  • Ultragenyx Pharmaceutical made up 0.01% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #1244 holding.
  • Capital Fund Management (CFM) first reported a position in Ultragenyx Pharmaceutical in Q1 2016 and has held it in 13 quarters since.
  • Capital Fund Management (CFM)'s Ultragenyx Pharmaceutical position peaked at $5.33M in Q3 2025.
  • 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.